Grants and Contributions:
Title:
Development of small-scale GMP production of mRNA and lipid nanoparticles
Agreement Number:
1035836
Agreement Value:
$698,000.00
Agreement Date:
Sep 30, 2025 - Sep 28, 2027
Description:
The project aims to establish small-scale GMP processes for producing messenger RNA and lipid nanoparticles, as well as targeted LNPs for research purposes. It responds to a need in personalized medicine for rare clinical batches.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Montreal, Quebec, CA H2W 1R7
Reference Number:
172-2025-2026-Q3-1035836
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
714255304
Recipient Type:
For-profit organization
Recipient's Operating Name:
ARN Technologies & Thérapeutiques
Recipient's Legal Name:
RNA Technologies & Therapeutics (RNA T&T) inc.
Federal Riding Name:
Laurier--Sainte-Marie
Federal Riding Number:
24039
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
325410